Dendritic cells: Limited potential in immunotherapy

International Journal of Biochemistry and Cell Biology

Volumn 37, Issue 2, 2005, Pages 241-245

  Soruri, Afsaneh ^a   Zwirner, Jörg ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Dendritic cells; Immunotherapy; Melanoma; Renal cell carcinoma

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; TUMOR VACCINE;

ANTIGEN PRESENTING CELL; CANCER; CELL MATURATION; CELL MIGRATION; DENDRITIC CELL; EXPERIMENTAL MODEL; HOMEOSTASIS; HUMAN; IMMUNE SYSTEM; IMMUNOTHERAPY; MELANOMA; NONHUMAN; REVIEW; T CELL LYMPHOMA; T LYMPHOCYTE; TUMOR IMMUNITY; TUMOR REGRESSION;

ANIMALIA;

EID: 4944267719     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2004.07.003     Document Type: Short Survey

References (22)

1. J. Banchereau, and R.M. Steinman Dendritic cells and the control of immunity Nature 392 1998 245 252
2. J. Banchereau, B. Schuler-Thurner, A.K. Palucka, and G. Schuler Dendritic cells as vectors for therapy Cell 106 2001 271 274
3. I.D. Davis, M. Jefford, P. Parente, and J. Cebon Rational approaches to human cancer immunotherapy Journal of Leukocyte Biology 73 2003 3 29
4. S. Grabbe, S. Beissert, T. Schwarz, and R.D. Granstein Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy? Immunology Today 16 1995 117 121
5. H.A. Haenssle, S. Emmert, S.W. Krause, M. Zutt, L. Kretschmer, and H. Schmidberger Phase I/II hybrid cell vaccination trial in metastatic melanoma without distinct clinical or immunologic effects Journal of Immunotheraphy 27 2004 147 155
6. K. Inaba, M. Inaba, N. Romani, H. Aya, M. Deguchi, and S. Ikehara Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor Journal of Experimental Medicine 176 1992 1693 1702
7. S.W. Krause, C. Neumann, A. Soruri, S. Mayer, J.H. Peters, and R. Andreesen The treatment of patients with disseminated malignant melanoma by vaccination with autologous cell hybrids of tumor cells and dendritic cells Journal of Immunotheraphy 25 2002 421 428
8. A. Kugler, G. Stuhler, P. Walden, G. Zoller, A. Zobywalski, and P. Brossart Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids Nature Medicine 6 2000 332 336 Retraction in: Kugler A, Stuhler G, Walden P, Zoller G, Zobywalski A, Brossart P, et al. 2003. Nature Medicine 9(9): 1221.
9. T. Maier, A. Tun-Kyi, A. Tassis, K.P. Jungius, G. Burg, and R. Dummer Vaccination of patients with cutaneous T-cell lymphoma using intranodal injection of autologous tumor-lysate-pulsed dendritic cells Blood 102 2003 2338 2344
10. F.O. Nestle, S. Alijagic, M. Gilliet, Y. Sun, S. Grabbe, and R. Dummer Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells Nature Medicine 4 1998 328 332
11. N. Romani, S. Gruner, D. Brang, E. Kampgen, A. Lenz, and B. Trockenbacher Proliferating dendritic cell progenitors in human blood Journal of Experimental Medicine 180 1994 83 93
12. F. Sallusto, and A. Lanzavecchia Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin-4 and downregulated by tumor necrosis factor α Journal of Experimental Medicine 179 1994 1109 1118
13. F. Sallusto, and A. Lanzavecchia Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression Immunological Reviews 177 2000 134 140
14. F. Santiago-Schwarz Positive and negative regulation of the myeloid dendritic cell lineage Journal of Leukocyte Biology 66 1999 209 216
15. E. Scandella, Y. Men, D.F. Legler, S. Gillessen, L. Prikler, and B. Ludewig CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2 Blood 103 2004 1595 1601
16. K. Schäkel, R. Kannagi, B. Kniep, Y. Goto, C. Mitsuoka, and J. Zwirner 6-sulfoLacNAc, a novel carbohydrate modification of PSGL-1, defines an inflammatory type of human dendritic cells Immunity 17 2002 289 301
17. G. Schuler, B. Schuler-Thurner, and R.M. Steinman The use of dendritic cells in cancer immunotherapy Current Opinion in Immunology 15 2003 138 147
18. A. Soruri, Z. Kiafard, C. Dettmer, J. Riggert, J. Kohl, and J. Zwirner IL-4 down-regulates anaphylatoxin receptors in monocytes and dendritic cells and impairs anaphylatoxin-induced migration in vivo Journal of Immunology 170 2003 3306 3314
19. A. Soruri, J. Riggert, T. Schlott, Z. Kiafard, C. Dettmer, and J. Zwirner Prostaglandin E2 and TNF-α induce differentiation of human monocytes into mature dendritic cells in a SCID mouse model Journal of Immunology 171 2003 2631 2636
20. S. Sozzani, P. Allavena, A. Vecchi, and A. Mantovani Chemokines and dendritic cell traffic Journal of Clinical Immunology 20 2000 151 160
21. R.M. Steinman Some interfaces of dendritic cell biology 111 2003 675 697
22. C. Zelle-Rieser, R. Ramoner, E. Artner-Dworzak, A. Casari, G. Bartsch, and M. Thurnher Human monocyte-derived dendritic cells are deficient in prostaglandin E2 production FEBS Letters 511 2002 123 126